Ovarian Neoplasms: all 2,757 studies
Page 25 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian CancerCompletedNCT00816764Phase 1
- Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00814086Phase 1
- Cost Utility Analysis in Recurrent Ovarian CancerWithdrawnNCT00813254
- Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian CancerCompletedNCT00804258
- FR in Stored PlasmaCompletedNCT00787514
- A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625)CompletedNCT00780039Phase 2
- Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian CancerCompletedNCT00772863Phase 2
- A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian CancerStatus unknownNCT00772798Phase 2
- AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CRCompletedNCT00770536Phase 1
- Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid TumorsCompletedNCT00765973Phase 1
- Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian CarcinomaTerminatedNCT00758732Phase 2
- Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine OlfactionCompletedNCT00757952
- Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United KingdomStatus unknownNCT00757263
- Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.WithdrawnNCT00753740Phase 2
- Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian CarcinomasCompletedNCT00750386Phase 1/2
- Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTerminatedNCT00748527Phase 2
- Bevacizumab and Carboplatin for Patients With Ovarian CancerCompletedNCT00744718Phase 2
- Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer RiskCompletedNCT00735150
- Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)CompletedNCT00722592Phase 2
- Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian CarcinomaCompletedNCT00721890Phase 2
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerStatus unknownNCT00719303Phase 3
- Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized StudyStatus unknownNCT00715286Phase 3
- Lymphadenectomy In Ovarian NeoplasmsCompletedNCT00712218Not applicable
- The Effect of TRA-8 on Ovarian Cancer TissueCompletedNCT00711932
- A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)CompletedNCT00709462Phase 1
- Ovarian Dendritic Cell Vaccine TrialStatus unknownNCT00703105Phase 2
- Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age ChildrenCompletedNCT00685256Phase 3
- Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversCompletedNCT00684801
- Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 MutationCompletedNCT00673335Phase 3
- PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal CancerCompletedNCT00672295Phase 1
- ChemoFx® PRO - A Post-Market Data Collection StudyTerminatedNCT00669422
- Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian CancerCompletedNCT00664781Phase 2
- Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian CancerStatus unknownNCT00660842Phase 3
- Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian CancerStatus unknownNCT00660101Phase 1/2
- Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of ProgressionWithdrawnNCT00659399Phase 1
- Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian CancerCompletedNCT00659178Phase 1
- Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free IntervalStatus unknownNCT00657878Phase 3
- Examining the Long-Term Risks of OophorectomyCompletedNCT00655447
- CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based ChemotherapyTerminatedNCT00653952Phase 3
- Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00652691Phase 1
- Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian OriginStatus unknownNCT00652119Phase 1
- Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian CancerCompletedNCT00648102Phase 1
- Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)CompletedNCT00635193Phase 1/2
- Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT00634894Phase 2
- Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female ParticipantsCompletedNCT00628654
- Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the OvaryCompletedNCT00626873Phase 1
- Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsCompletedNCT00620295Phase 1
- Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.CompletedNCT00620243Early Phase 1
- Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing RegimensWithdrawnNCT00610792Phase 2
- Telemedicine vs. Face-to-Face Cancer Genetic CounselingCompletedNCT00609505Not applicable
- A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial CancerCompletedNCT00607607Phase 2
- DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal CancerWithdrawnNCT00603460Phase 1/2
- Sexual Functioning After Primary Treatment of Ovarian CancerTerminatedNCT00596544
- Women Surviving Ovarian CancerCompletedNCT00596349
- Bone Health in Gynecologic Cancers-does FOSAVANCE Help?CompletedNCT00593580Phase 2
- Estrogen, Diet, Genetics and Endometrial CancerActive, not recruitingNCT00587886
- A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian CancerCompletedNCT00587093Not applicable
- Genetic Studies in Breast CancerCompletedNCT00582322
- Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsActive, not recruitingNCT00579514Not applicable
- Clinical Significance of Germline BRCA MutationsActive, not recruitingNCT00579488
- Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersActive, not recruitingNCT00579163
- Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological TumorsCompletedNCT00569257Phase 2
- Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian CancerCompletedNCT00563836Phase 2
- Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian CancerWithdrawnNCT00562185Phase 1/2
- Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer PatientsCompletedNCT00562003Phase 1
- Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical TrialStatus unknownNCT00551577Phase 2
- Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line ChemotherapyWithdrawnNCT00551265Not applicable
- Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase InhibitorCompletedNCT00543049Phase 2
- TAX + Carboplatin or Cisplatin 1st Line Post-Surgery OvarianCompletedNCT00539669Phase 2
- Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)CompletedNCT00538603Not applicable
- Hydralazine Valproate for Ovarian CancerStatus unknownNCT00533299Phase 3
- An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian CancerStatus unknownNCT00532194Phase 3
- NYU Ovarian Cancer Early Detection Program Blood and GeneticsTerminatedNCT00531778
- Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian CarcinomaCompletedNCT00531570
- Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian CancerCompletedNCT00529022Phase 1
- Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian CancerStatus unknownNCT00527631Phase 1
- A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer PatientsCompletedNCT00526617Phase 1
- Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual FunctionCompletedNCT00525460
- Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian CancerCompletedNCT00523380Phase 2
- Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This QuestionnaireCompletedNCT00517621Phase 2
- A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal CancerTerminatedNCT00516841Phase 2
- A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)CompletedNCT00516373Phase 1
- Depression Treatment and Screening in Ovarian Cancer PatientsActive, not recruitingNCT00515372Phase 1
- Phase 1 Study of OSI-930 in Cancer PatientsCompletedNCT00513851Phase 1
- Quality of Life Associated With a Low-Risk Screening Program for Ovarian CancerStatus unknownNCT00511641
- Chemotherapy-Related Toxicities In Ovarian Cancer PatientsCompletedNCT00508378
- Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube CancerStatus unknownNCT00499512
- Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian CancerCompletedNCT00490711Phase 2
- Advanced Ovarian Cancer and Sexuality Phase 1CompletedNCT00488202
- Ovarian Cancer Patient Questionnaire on Genetic TestingCompletedNCT00486707
- Platinum-Resistant, Recurrent Epithelial Ovarian CancerWithdrawnNCT00484666
- Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian CancerCompletedNCT00484432Phase 2
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00483782Phase 3
- Dendritic Cell Vaccine for High Risk Ovarian Cancer PatientsCompletedNCT00478452Phase 1
- Ovarian Cancer and Immune Response to Flu VaccineCompletedNCT00478387
- Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172WithdrawnNCT00477867Not applicable
- Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian CancerCompletedNCT00477282Phase 3
- Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursCompletedNCT00475956Phase 1
- A Phase I Study of Intraperitoneal Hyperthermic DocetaxelCompletedNCT00474669Phase 1
- Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian CancerCompletedNCT00473954Phase 1